Exchange: NASDAQ·Updated 09:34 AM EST

About OPT

About

Ceryvyn Therapeutics Ltd. is a clinical stage biopharmaceutical company, which engages in the development and research of novel therapeutic products based on targeting Vascular Endothelial Growth Factors. It operates through the United States and Australia geographical segments. The company was founded by Dr. Megan Baldwin on October 17, 1984, and is headquartered in Melbourne, Australia.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
N/A

Frequently Asked Questions

Advertisement|Remove ads.